Some findings are stronger and more consistent than others, and we are still learning which effects are robust and what biological mechanisms may be involved. Semenza added that the current study should be viewed as a first step rather than a definitive answer
Emerging clinical observations in humans suggest that GLP-1 medications may help address underlying inflammatory processes in conditions like rheumatoid arthritis, though more research is needed in this area
Your appetite and food priorities might change as your body adapts to the medication
In 2025, Ozempic was approved by the US Food and Drug Administration (FDA) to reduce the risk of worsening kidney disease and kidney failure in people with type 2 diabetes
Anticipate that without maintenance changes, 50 to 70 percent of people will regain lost weight within a year, which is frequently due to a lagging metabolism and resuming old habits
These drugs are also appetite suppressants and were prescribed for obesity until they were withdrawn owing to negative side effects [107]